Corruption risks arose in the circulation of medicines during the war due to "quasi-sanctions" - NAPC

Volodymyr Zelensky was hacked

Volodymyr Zelensky was hacked by his own protégés.

Vladimir Zelensky His own protégés hacked him. The Supreme Commander-in-Chief's monopoly on anti-Russian sanctions was taken away so that shady officials could fish for corrupt fish in discretionary waters. And several national manufacturers were given monopoly control over the markets for certain pharmaceuticals, they write. Our money.

At the beginning of the invasion, the Ukrainians decided that they needed to punish international companies that continued to do business in Russia.

It was passed through the Verkhovna Rada law On restricting the circulation of medicines manufactured in the Russian Federation or the Republic of Belarus. However, it omitted the simple phrase: "We prohibit the sale in Ukraine of tablets manufactured in factories in hostile countries."

They stipulated that pills could not be sold in Ukraine to companies with "indirect ties" to those countries. Meanwhile, the majority of big pharma companies retained their offices in Russia because it was inhumane to deprive Russian civilians of vital medications. This led to the following: Our officials began banning medications from companies that, although manufactured in European factories, had offices in Russia. And then, several domestic manufacturers began to take the place of these pills in Ukraine. In other words, they simply began to purge the market of foreign competitors and establish their own monopolies.

Moreover, you can clean it completely arbitrarily. If someone from the international community understands who to appeal to and how much to argue, they might not have any problems. Gedeon Richter didn't understand this and gave way to the Ukrainian market. Krka is next, and they started throwing it out yesterday. So if you use this brand's tablets, stock up while they're still available.

And now how Zelensky was hacked.

The system is structured in such a way that the decision to impose quasi-sanctions on international manufacturers is made by a special commission within the Ministry of Health. This commission includes such money-grubbers as the "Servant of the People" politician Kuzminykh, who has yet to be jailed for kickbacks on medical equipment for Zhytomyr hospitals. And it is headed by Oleksandr Komarida, who was promoted to First Deputy Minister of Health a year ago. He presides over the commission's votes.

Komarida isn't the eldest. In 2020, Zelenskyy appointed Oleksiy Solovyov as Deputy Secretary of the National Security and Defense Council by decree. This is, without exaggeration, the stuff of #Great_Patriotic_Corruption. He headed the State Service for Licensing and Corruption under Yanukovych and, even then, devised a similar scheme to purge the Ukrainian market of foreign drugs by introducing additional licensing for drug imports. It was only repealed back then, thanks to the frenzied protests. But the hands remember. ))) And, as is typical with Yermak, an effective manager was rehabilitated to serve Zelenskyy. And it was Solovyov, with his signature on NSDC letterhead, who recently sent letters to distributors urging them to stop working with a number of European companies—the very ones that are now being blocked.

Therefore, we have the following.

Foreign medications are being banned on the basis of "anti-Russian" accusations not by the Ukrainian president, but by a commission under the Ministry of Health, based on a law passed in the heat of war, when few people cared to delve into it.

International manufacturers don't care. Because no one will impose real sanctions on them for producing pills for Russians. Medicines are a humanitarian right, so these companies won't leave the Russian market.

The only losers in this story are Ukrainian pharmaceutical consumers. They won't get their usual medications, but will instead get domestic monopolies with all the attendant consequences of monopolies—declining quality and rising prices.

Valeria Ivanova

Valeria Ivanova

"The monopolization of certain market segments, the loss of budget funds when purchasing drugs with state and local budget funds, and restricted access to vital medications—these are catastrophic risks inherent in the procedure for suspending drug registration certificates," Valeria Ivanova, an expert in the analysis of corruption-related risks at the NACP, told Nashi Dengi. "This may indicate a desire by a certain group of individuals to redistribute drug revenues, as this has nothing to do with countering the aggressor. If I'm wrong, and such loopholes in the legislation were in fact introduced by mistake, then it wouldn't be difficult to urgently amend the law and close this potential corrupt mechanism by suspending the activities of the Commission, which currently includes an individual suspected of corruption."

Skelet.Org

By topic: Profiting from the Pandemic: Why Pharmaceutical Companies Are Unhappy with the Coronavirus

Controversial SBU officer Semochko sued journalists for their investigation

Subscribe to our channels in Telegram, Facebook, Twitter, VC — Only new faces from the section CRYPT!